drugset / Trial / NCT01813461
Study to Evaluate the Pharmacokinetics of 14C-labeled Isavuconazole Following a Single Oral Dose of 14C-labeled Prodrug Isavuconazonium Sulfate (BAL8557) in Healthy Male Subjects
Phase 1
Completed
8 enrolled
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd · collab
NaSingle-groupOpen-label
Summary
The purpose of this study is to evaluate the pharmacokinetics of 14C-labeled isavuconazole and the routes of excretion and the extent of metabolism of 14C-labeled prodrug BAL8557.
Timeline
- Start
- 2012-10
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isavuconazonium | Small molecule | — | Oral |
Indications
No indication recorded.